Post-translational control of chemokines: a role for,decoy receptors?

被引:60
作者
Comerford, L
Nibbs, RJB
机构
[1] Beatson Inst Canc Res, Canc Res UK Beatson Labs, Glasgow G61 1BD, Lanark, Scotland
[2] Univ Glasgow, Div Immunol Infect & Inflammat, Glasgow G12 8QQ, Lanark, Scotland
关键词
chemokines; leukocyte migration; decoy receptors proteases; viral homologues; antagonists;
D O I
10.1016/j.imlet.2004.08.018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is well-established that chemokines play a critical role in the orchestration of inflammation and immunity. Interactions between chemokines and their receptors are essential for the homing of specific subsets of leukocytes to their functional microenvironments. They also influence other diverse biological processes such as development, leukocyte activation, Th1/Th2 polarisation, tumour metastasis, angiogenesis, and HIV pathogenesis. However, despite their importance, only now are we beginning to understand the complex regulation brought to bear on these molecules. In this review, we discuss a number of these key chemokine regulators that exert their influence once these proteins have been synthesised. We examine (i) chemokine storage, release, and presentation, (ii) protease regulation, (iii) viral manipulation of host chemokines, and (iv) natural mammalian receptor antagonists. Principally, the growing evidence for a role for decoy receptors in the chemokine system is discussed. In particular, the potential decoy function of the 'silent' pro-inflammatory chemokine receptor D6 is described alongside two other candidate decoy receptor molecules, DARC, and CCX-CKR. Dissecting the biological and pathological function of these chemokine controllers will lead to a deeper understanding of chemokine regulation, and may reveal novel strategies to therapeutically modify the chemokine system. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:163 / 174
页数:12
相关论文
共 95 条
[61]  
NEOTE K, 1994, BLOOD, V84, P44
[62]  
NEOTE K, 1993, J BIOL CHEM, V268, P12247
[63]   Chemokines on the move: control by the chemokine "interceptors" Duffy blood group antigen and D6 [J].
Nibbs, R ;
Graham, G ;
Rot, A .
SEMINARS IN IMMUNOLOGY, 2003, 15 (05) :287-294
[64]   C-C chemokine receptor 3 antagonism by the β-chemokine macrophage inflammatory protein 4, a property strongly enhanced by an amino-terminal alanine-methionine swap [J].
Nibbs, RJB ;
Salcedo, TW ;
Campbell, JDM ;
Yao, XT ;
Li, YL ;
Nardelli, B ;
Olsen, HS ;
Morris, TS ;
Proudfoot, AEI ;
Patel, VP ;
Graham, GJ .
JOURNAL OF IMMUNOLOGY, 2000, 164 (03) :1488-1497
[65]   Cloning and characterization of a novel promiscuous human β-chemokine receptor D6 [J].
Nibbs, RJB ;
Wylie, SM ;
Yang, JY ;
Landau, NR ;
Graham, GJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) :32078-32083
[66]   The β-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors [J].
Nibbs, RJB ;
Kriehuber, E ;
Ponath, PD ;
Parent, D ;
Qin, SX ;
Campbell, JDM ;
Henderson, A ;
Kerjaschki, D ;
Maurer, D ;
Graham, GJ ;
Rot, A .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (03) :867-877
[67]   The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS [J].
O'Brien, SJ ;
Moore, JP .
IMMUNOLOGICAL REVIEWS, 2000, 177 :99-111
[68]   Unusual chemokine receptor antagonism involving a mitogen-activated protein kinase pathway [J].
Ogilvie, P ;
Thelen, S ;
Moepps, B ;
Gierschik, P ;
Campos, ACD ;
Baggiolini, M ;
Thelen, M .
JOURNAL OF IMMUNOLOGY, 2004, 172 (11) :6715-6722
[69]   Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes [J].
Ogilvie, P ;
Paoletti, S ;
Clark-Lewis, I ;
Uguccioni, M .
BLOOD, 2003, 102 (03) :789-794
[70]  
Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851